Cipla (CIPLA) — Corporate Action

Cipla Limited allotted 585 fully paid-up equity shares of ₹2 face value each on 17th December 2025 under its ESOS 2013-A and ESAR 2021 schemes following employee stock option exercises. The company's issued capital increased to ₹1,61,55,43,596 comprising 80,77,71,798 equity shares. This represents minimal dilution from employee compensation plans.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"How does this corporate action affect Cipla Limited's outlook?" "What did Cipla Limited announce on 17 December 2025?" "Is this positive or negative for CIPLA?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 17 December 2025

ICICIBANK ICICI Bank Limited Offer Document MARICO Marico Limited Announcement SBIN State Bank of India Board Meeting HDFCLIFE HDFC Life Insurance Company Limited Board Meeting JIOFIN Jio Financial Services Limited Board Meeting OFSS Oracle Financial Services Software Limited Board Meeting

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.